Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | USP30 | Q70CQ3 | 9/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KCNJ6 | P48051 | 1/20 | 0.38 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.38 |
| ▸ | KCNJ3 | P48549 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16826161 | 1.00 | LMNA (0.46) | LMNAUSP30TP53ADORA2AMAPT | |
| SCHEMBL16848081 | 0.91 | LMNA (0.46) | LMNAUSP30TP53MAPT | |
| SCHEMBL16848105 | 0.89 | LMNA (0.42) | LMNAUSP30TP53MAPTMAPK1 | |
| SCHEMBL29911888 | 0.89 | RORC (0.43) | LMNAUSP30TP53MAPTMAPK1 | |
| SCHEMBL16826018 | 0.89 | RORC (0.43) | LMNAUSP30TP53MAPTMAPK1 | |
| SCHEMBL16826123 | 0.88 | TP53 (0.41) | LMNAUSP30TP53MAPTMAPK1 | |
| SCHEMBL18169442 | 0.88 | USP30 (0.47) | LMNAUSP30TP53MAPT | |
| SCHEMBL16826264 | 0.88 | MAPT (0.51) | LMNAUSP30TP53MAPTMAPK1 | |
| SCHEMBL16826438 | 0.86 | USP30 (0.53) | LMNAUSP30TP53MAPTMAPK1 | |
| SCHEMBL16848172 | 0.85 | TP53 (0.41) | LMNAUSP30TP53MAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250137069-A1 | KIT FOR IDENTIFYING MALIGNANCY, AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2025-05-01 | — | — | US | disclosed |
| US-12209287-B2 | Kit for identifying malignancy, and uses thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2025-01-28 | — | — | US | disclosed |
| US-20230366031-A1 | KIT FOR IDENTIFYING MALIGNANCY, AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2023-11-16 | — | — | US | disclosed |
| US-11649505-B2 | Kit for identifying malignancy, and uses thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2023-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11649505-B2 | Kit for identifying malignancy, and uses thereof | KIT, WNT1, WNT3 | LMNA 3171/4885USP30 1963/4885TP53 449/4885 |
| US-12209287-B2 | Kit for identifying malignancy, and uses thereof | KIT, WNT1, WNT3 | LMNA 3171/4885USP30 1963/4885TP53 449/4885 |
| US-20230366031-A1 | KIT FOR IDENTIFYING MALIGNANCY, AND USES THEREOF | KIT, WNT1, WNT3 | LMNA 3171/4885USP30 1963/4885TP53 449/4885 |
| US-20250137069-A1 | KIT FOR IDENTIFYING MALIGNANCY, AND USES THEREOF | WNT1, KIT, WNT3 | LMNA 1575/4885USP30 1035/4885TP53 112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.